Latest NINDS brain trauma research Stories
In 2011, the National Institute of Neurological Disorders and Stroke (NINDS) convened the Stroke Progress Review Group (SPRG) to conduct a final 10-year review of the state of stroke research.
In the US alone, at least 500,000 people suffer from Parkinson's disease, a neurological disorder that affects a person's ability to control his or her movement.
For years, researchers seeking new therapies for traumatic brain injury have been tantalized by the results of animal experiments with stem cells.
A protective molecule has been identified in the brain which, if used artificially, may prevent brain damage from the likes of stroke, head injury and Alzheimer's.
New data offer hints to why Parkinson's disease so selectively harms brain cells that produce the chemical dopamine.
When Geoffrey Murphy, Ph.D., talks about plastic structures, he's not talking about the same thing as Mr. McGuire in The Graduate.
BETHESDA, Md., Jan. 27, 2011 /PRNewswire/ -- BrainScope Company, Inc. today announced its sponsorship of a multi-center, observational clinical study, the "B-Ahead U.K.
Stem cells derived from the endometrium (uterine lining) and transplanted into the brains of laboratory mice with Parkinson's disease appear to restore functioning of brain cells damaged by the disease.
There is a new â€œHUMMRâ€ on the block. It is smaller than its automotive counterpart, but no less powerful.
Scientists have identified a protein in the brain that plays a key role in the function of mitochondria â€“ the part of the cell that supplies energy, supports cellular activity, and potentially wards off threats from disease.